Changes in craving for a cigarette and arterial nicotine plasma concentrations in abstinent smokers

被引:15
作者
Guthrie, SK
Ni, LS
Zubieta, JK
Teter, CJ
Domino, EF
机构
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Radiol Nucl Med, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Subst Abuse Res Ctr, Ann Arbor, MI 48109 USA
关键词
abstinent smokers; cigarette; craving; nicotine; pharmacokinetics; tobacco smoke;
D O I
10.1016/j.pnpbp.2004.01.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although the relationship between nicotine and changes in heart rate and blood pressure has been demonstrated, the relationship between nicotine and subjective effects such as decreased craving, relaxation, sickness, and decreased nervousness, is less well delineated. In this study, arterial nicotine levels were drawn in 21 smokers who smoked two average nicotine (AN) cigarettes and one low nicotine (LN) cigarette. Craving for a cigarette, relaxation, sickness, and decreased nervousness were rated on a visual analog scale (VAS) before and after smoking each cigarette. None of these subjective measures except craving for a cigarette was changed significantly by smoking. The change in craving was significantly correlated with the area under the plasma nicotine concentration versus time curve (r = -0.57, p = 0.01) calculated from the arterial nicotine samples drawn up to 20 min after the initiation of smoking the first AN cigarette. Although well-documented behavioral manipulations, such as smoking denicotinized cigarettes, reduce craving, increases in plasma arterial nicotine concentrations after smoking the first cigarette of the day also reduce craving. Both the psychology and pharmacology of nicotine/tobacco smoking are involved in craving reduction. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:617 / 623
页数:7
相关论文
共 21 条
[1]  
BENOWITZ NL, 1982, J PHARMACOL EXP THER, V221, P368
[2]  
BENOWITZ NL, 1990, J PHARMACOL EXP THER, V254, P1000
[3]   Cigarette smoking [J].
Bergen, AW ;
Caporaso, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (16) :1365-1375
[4]  
Brauer L H, 2001, Nicotine Tob Res, V3, P101
[5]  
Buchhalter A R, 2001, Nicotine Tob Res, V3, P111
[6]  
Fattinger K, 1997, J PHARMACOL EXP THER, V281, P1238
[7]  
First S., 1995, BIOMETRICS RES DEP
[8]   Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine [J].
Gourlay, SG ;
Benowitz, NL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (04) :453-463
[9]   Arterial/venous plasma nicotine concentrations following nicotine nasal spray [J].
Guthrie, SK ;
Zubieta, JK ;
Ohl, L ;
Ni, L ;
Koeppe, RA ;
Minoshima, S ;
Domino, EF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (09) :639-643
[10]  
HARIHARAN M, 1988, CLIN CHEM, V34, P724